154 related articles for article (PubMed ID: 646971)
1. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
[TBL] [Abstract][Full Text] [Related]
2. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
Isaacs AJ; Havard CW
Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
[TBL] [Abstract][Full Text] [Related]
3. Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
Fiet J; Hermano M; Witte J; Villette JM; Haimart M; Gourmel B; Tabuteau F; Rouffy J; Dreux C
Acta Endocrinol (Copenh); 1982 Sep; 101(1):93-7. PubMed ID: 6812348
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Englund DE; Johansson ED
Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384
[TBL] [Abstract][Full Text] [Related]
5. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
[TBL] [Abstract][Full Text] [Related]
6. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U
Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
[TBL] [Abstract][Full Text] [Related]
7. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
Thom MH; Collins WP; Studd JW
Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
[TBL] [Abstract][Full Text] [Related]
8. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
9. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
Sipinen S
Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
van der Mooren MJ; Demacker PN; Thomas CM; Rolland R
Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
Englund DE; Victor A; Johansson ED
Maturitas; 1981 Aug; 3(2):125-33. PubMed ID: 6793811
[TBL] [Abstract][Full Text] [Related]
12. The absorption and metabolism of oral oestradiol, oestrone and oestriol.
Townsend PT; Dyer GI; Young O; Whitehead MI; Collins WP
Br J Obstet Gynaecol; 1981 Aug; 88(8):846-52. PubMed ID: 6789863
[TBL] [Abstract][Full Text] [Related]
13. [Estradiol-17beta, estrone, LH and FSH in serum after administration of estradiol-17beta, estradiolbenzoate, estradiol-valeriate and estradiol-undecylate in the female (author's transl)].
Leyendecker G; Geppert G; Nocke W; Ufer J
Geburtshilfe Frauenheilkd; 1975 May; 35(5):370-4. PubMed ID: 1150068
[TBL] [Abstract][Full Text] [Related]
14. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
15. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen and partial oestrogen agonism in postmenopausal women.
Miodrag A; Ekelund P; Burton R; Castleden CM
Age Ageing; 1991 Jan; 20(1):52-4. PubMed ID: 1903020
[TBL] [Abstract][Full Text] [Related]
17. Absorption of percutaneous oestradiol in postmenopausal women.
Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P
Maturitas; 1980 Oct; 2(3):207-11. PubMed ID: 6777634
[TBL] [Abstract][Full Text] [Related]
18. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
19. Hormonal profiles after the menopause.
Chakravarti S; Collins WP; Forecast JD; Newton JR; Oram DH; Studd JW
Br Med J; 1976 Oct; 2(6039):784-7. PubMed ID: 974609
[TBL] [Abstract][Full Text] [Related]
20. Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol.
Pattison NS; Uptin T; Knox B; France J
Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):62-5. PubMed ID: 2562605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
